14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $22.23 $23.98 Thursday, 25th Apr 2024 EXEL stock ended at $23.53. This is 0.759% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 1.65% from a day low at $23.36 to a day high of $23.74.
90 days $20.02 $24.07
52 weeks $18.08 $24.34

Historical Exelixis prices

Date Open High Low Close Volume
Aug 15, 2023 $21.59 $21.62 $21.47 $21.56 1 412 358
Aug 14, 2023 $21.50 $21.76 $21.44 $21.51 2 488 445
Aug 11, 2023 $21.18 $21.59 $21.18 $21.52 2 478 745
Aug 10, 2023 $20.70 $21.16 $20.68 $21.15 2 569 263
Aug 09, 2023 $20.48 $20.82 $20.44 $20.62 2 443 497
Aug 08, 2023 $20.18 $20.57 $20.02 $20.50 4 854 349
Aug 07, 2023 $20.30 $20.47 $20.17 $20.25 1 812 029
Aug 04, 2023 $20.68 $20.70 $20.23 $20.27 2 841 213
Aug 03, 2023 $20.45 $20.79 $20.22 $20.76 2 858 105
Aug 02, 2023 $20.00 $20.74 $19.98 $20.34 4 906 656
Aug 01, 2023 $19.74 $19.79 $19.55 $19.63 1 936 310
Jul 31, 2023 $19.84 $19.88 $19.51 $19.71 1 148 173
Jul 28, 2023 $19.66 $19.89 $19.65 $19.85 1 658 700
Jul 27, 2023 $19.87 $19.96 $19.57 $19.60 2 120 908
Jul 26, 2023 $19.76 $19.95 $19.59 $19.82 1 842 043
Jul 25, 2023 $19.79 $20.00 $19.72 $19.77 1 385 736
Jul 24, 2023 $19.76 $20.19 $19.76 $19.89 2 012 165
Jul 21, 2023 $19.98 $20.04 $19.68 $19.69 1 620 705
Jul 20, 2023 $19.64 $19.88 $19.63 $19.87 1 557 080
Jul 19, 2023 $19.31 $19.60 $19.31 $19.54 1 971 029
Jul 18, 2023 $19.19 $19.66 $19.16 $19.30 2 544 712
Jul 17, 2023 $19.39 $19.57 $19.19 $19.19 1 695 539
Jul 14, 2023 $19.34 $19.51 $19.32 $19.39 1 505 250
Jul 13, 2023 $19.38 $19.54 $19.23 $19.35 1 243 055
Jul 12, 2023 $19.22 $19.45 $19.10 $19.37 1 144 442
Click to get the best stock tips daily for free!

About Exelixis

Exelixis Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA... EXEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT